Joey Azofeifa
Chief Executive Officer & Co-Founder Arpeggio Bio
Seminars
Wednesday 29th October 2025
Orally Bioavailable NRF2 Molecular Glue Degrader Effective in KEAP1-Mutant Cancer
11:30 am
